Schlafen 11 predicts response to platinum-based chemotherapy in gastric cancers.

Tsuyoshi TakashimaDaiki TaniyamaNaoya SakamotoMaika YasumotoRyuichi AsaiTakuya HattoriRirino HonmaQuoc Thang PhamShoichi UkaiRyota MaruyamaKenji HaradaKazuya KuraokaKazuaki TanabeAtsuo T SasakiHideki OhdanEiichi MoriiJunko MuraiWataru Yasui

Published in: British journal of cancer (2021)

This is the first report revealing definitive clinical implications of SLFN11 in the treatment of GC patients and providing novel strategies for the drug selection based on SLFN11 expression.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
locally advanced
peritoneal dialysis
prognostic factors
squamous cell carcinoma
patient reported outcomes
radiation therapy
high resolution
mass spectrometry
gas chromatography